Image

Intervention for Communication Quality of Life in Primary Progressive Aphasia

Intervention for Communication Quality of Life in Primary Progressive Aphasia

Recruiting
40 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to determine whether individually tailored speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of dementia that affects speech and language. The study will be offered to individuals who speak English and/or Spanish. The study will also document how acceptable and beneficial the program is to both patients and their care partners.

The main questions the study aims to answer are:

  1. Is the telerehabilitation program feasible and acceptable for people with PPA and their care partners?
  2. Do participants with PPA and care partners find treatment beneficial?
  3. Which outcome measures are most useful for evaluating changes in communication and quality of life?
  4. What patterns of treatment response are seen in participants after completing the program?

The program includes both speech-language therapy and training for care partners.

Participants with PPA will:

  1. Complete virtual communication tasks and questionnaires before and after the program
  2. Take part in online speech-language therapy sessions
  3. Include their care partners in some parts of the program for training and support

Eligibility

Inclusion Criteria for Persons with PPA:

  • A PPA (Gorno-Tempini et al., 2011) or "PPA-plus" (Mesulam et al., 2001) diagnosis
  • MMSE score of > 15 and must be able to produce single monosyllabic words intelligibly.
  • Must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
  • Hearing and vision adequate for participation in teleconference meetings
  • Must have a care partner available (someone who will commit to attending teleconference sessions weekly during treatment phases)

Inclusion criteria for Care Partners:

  • Partners must express willingness to attend and participate in treatment sessions including those targeting dyadic communication goals
  • Partners must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
  • Partner's hearing and vision should be adequate for participation in teleconference meetings

Exclusion criteria for persons with PPA:

  • Other central nervous system or medical diagnosis that can account for symptoms
  • Psychiatric diagnosis that can account for symptoms
  • The participant and/or study partner must have basic experience using a computer.

Study details
    Primary Progressive Aphasia(PPA)
    Semantic Dementia
    Logopenic Progressive Aphasia (LPA)
    Nonfluent Aphasia
    Progressive
    Progressive Aphasia
    Semantic Variant Primary Progressive Aphasia (svPPA)
    Semantic Aphasia
    Logopenic Variant Primary Progressive Aphasia
    Logopenic Variant of Primary Progressive Aphasia (LPA)
    Logopenic Progressive Aphasia
    Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
    Nonfluent Progressive Aphasia

NCT07219680

University of Texas at Austin

1 November 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.